{"gene":"ELL","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1996,"finding":"ELL encodes an RNA polymerase II elongation factor that increases the catalytic rate of transcription by suppressing transient pausing by RNA polymerase II at multiple sites along DNA templates.","method":"In vitro transcription elongation assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro biochemical assay establishing enzymatic mechanism, foundational paper with >297 citations","pmids":["8596958"],"is_preprint":false},{"year":1994,"finding":"ELL (eleven-nineteen lysine-rich leukemia) was identified as the gene fusing to MLL in the t(11;19)(q23;p13.1) translocation in acute myeloid leukemia; predicted protein contains a highly basic, lysine-rich motif homologous to the DNA-binding domain of poly(ADP-ribose) polymerase.","method":"PCR cloning from patient leukemia cDNA library, Northern blot, zoo blot evolutionary conservation analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — molecular cloning with multiple orthogonal methods, foundational identification paper","pmids":["7991593"],"is_preprint":false},{"year":2000,"finding":"MLL-ELL fusion protein immortalizes myeloid progenitors and causes acute myeloid leukemia in mice; ELL alone has no transforming effect, establishing that MLL fusion drives oncogenesis.","method":"Retroviral transduction of murine hematopoietic progenitors, serial replating assay, bone marrow transplantation into lethally irradiated mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean in vivo mouse model with defined phenotypic readout, replicated across 20 animals","pmids":["10995463"],"is_preprint":false},{"year":2000,"finding":"The carboxy-terminal R4 domain of ELL (not the elongation domain) is both necessary and sufficient for MLL-ELL-mediated immortalization of myeloid progenitors; the R4 domain has potent transcriptional activation properties and transactivates a HoxA7 promoter.","method":"Structure-function analysis with truncation/deletion mutants, retroviral transduction serial replating assay, transient transfection transcriptional assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis combined with functional cellular and transcriptional assays","pmids":["11090074"],"is_preprint":false},{"year":2001,"finding":"The EAF1 interaction domain of ELL (not the elongation domain) is critical for MLL-ELL-mediated leukemogenic transformation; MLL-EAF1 fusion alone is sufficient to immortalize myeloid progenitors and induce AML in vivo, suggesting recruitment of an EAF1-like transactivation domain is a common mechanism of 11q23 leukemogenesis.","method":"Structure-function analysis of MLL-ELL mutants, retroviral bone marrow transduction, in vitro transformation assay, mouse bone marrow transplantation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis with in vitro and in vivo confirmation, multiple orthogonal approaches","pmids":["11463848"],"is_preprint":false},{"year":1997,"finding":"ELL2 is a novel RNA polymerase II elongation factor 49% identical to ELL; ELL2 and ELL possess similar transcriptional elongation activities; the elongation activation domain maps to the N-terminal region of ELL2 that is highly homologous to ELL.","method":"Molecular cloning, in vitro transcription elongation assay, Northern blot, structure-function analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro elongation assay with domain mapping, directly characterizing ELL family mechanism","pmids":["9108030"],"is_preprint":false},{"year":1999,"finding":"EAP30 subunit of the ELL complex interacts with ELL and derepresses ELL's inhibitory activity on RNA polymerase II promoter-specific transcription in vitro; ELL has a novel RNA polymerase II interaction domain capable of repressing polymerase activity, which is deleted in AML translocations.","method":"In vitro transcription assay, protein interaction studies, sequence homology to S. cerevisiae SNF8","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical reconstitution establishing derepression mechanism","pmids":["10419521"],"is_preprint":false},{"year":2001,"finding":"ELL (along with TFIIF and Elongin) suppresses transient pausing by RNA polymerase II by preventing displacement of the 3′ end of the nascent transcript from the polymerase catalytic site, and inhibits SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates.","method":"In vitro transcription and nascent transcript cleavage assays with purified factors","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mechanistic dissection of elongation versus cleavage activities","pmids":["11259417"],"is_preprint":false},{"year":2002,"finding":"EAF2 (ELL Associated Factor 2) physically interacts with ELL via an amino-terminal interaction domain of ELL; ELL and EAF2 colocalize in a nuclear speckled pattern; EAF2 contains a transcriptional activation domain; MLL-ELL disrupts normal ELL protein-protein interactions by retaining EAF1 but not EAF2 interaction.","method":"Co-immunoprecipitation with specific antibodies, confocal microscopy, retroviral bone marrow transduction transformation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, co-localization, and functional transformation assay, multiple orthogonal methods","pmids":["12446457"],"is_preprint":false},{"year":2003,"finding":"ELL and EAF1 are components of Cajal bodies (CBs); their localization in CBs is dependent on active RNA polymerase II transcription (dispersed by actinomycin D, DRB, or alpha-amanitin); CBs are disrupted in MLL-ELL leukemia cells with delocalization of EAF1 and p80 coilin.","method":"Immunofluorescence colocalization with p80 coilin, pharmacological inhibition of Pol II, nuclear/cytoplasmic fractionation, confocal microscopy in MLL-ELL leukemia cells","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — direct localization with functional consequence via transcription inhibition and leukemia cell comparison","pmids":["12686606"],"is_preprint":false},{"year":2003,"finding":"MLL-ELL inhibits p53 functional activity more efficiently than wild-type ELL; the extreme C-terminus of ELL (ELL eCT) recruits p53 into MLL-ELL nuclear foci and is necessary and sufficient for MLL-ELL inhibition of p53-mediated p21 induction and apoptosis; MLL-ELL disrupts p53 interactions with p300/CBP and reduces p53 acetylation in vivo.","method":"Transient transfection, co-immunoprecipitation, p53 acetylation assay, apoptosis assay, p21 induction assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including protein interaction, PTM analysis, and functional readouts","pmids":["12773566"],"is_preprint":false},{"year":1997,"finding":"Murine ELL protein localizes to the nucleus but is excluded from nucleoli in multiple cell lines (COS-7, HeLa, NIH 3T3, A7r5), consistent with its function as an RNA polymerase II elongation factor.","method":"Immunofluorescence with polyclonal antiserum to ELL, subcellular localization in multiple cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment across multiple cell lines, single lab","pmids":["9037066"],"is_preprint":false},{"year":2005,"finding":"ELL physically interacts with the mineralocorticoid receptor (MR) N-terminal domain and acts as a selective coactivator of MR; ELL differentially modulates steroid receptor responses with opposite effects on MR versus glucocorticoid receptor, without affecting androgen or progesterone receptors; both the elongation domain and EAF1 interaction domain are required for ELL's coactivator function.","method":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, transient transfection transcriptional assays with deletion/point mutants","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including pulldown, Co-IP, mutagenesis, and transcriptional assays","pmids":["15650021"],"is_preprint":false},{"year":2008,"finding":"Drosophila ELL (dELL) is recruited to heat shock loci upon induction and is required for proper heat-shock gene expression; dELL knockdown reduces levels of phosphorylated (elongating) RNA Pol II at heat-shock loci; dELL and its associated factor dEaf are both essential for fly development.","method":"RNAi knockdown in Drosophila, chromatin immunoprecipitation at heat shock loci, phospho-Pol II immunostaining","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — RNAi loss-of-function with ChIP and molecular phenotype in a metazoan model organism","pmids":["18562276"],"is_preprint":false},{"year":2009,"finding":"ELL directly binds to the thrombospondin-1 (TSP-1) promoter and transactivates TSP-1 gene expression; DNA binding maps to the first 45 amino acids of ELL; the ELL response element maps to -1426 to -1418 of the TSP-1 promoter; MLL-ELL (lacking the N-terminal 45 aa) cannot induce TSP-1; ELL inhibits zebrafish vasculogenesis in part through TSP-1 upregulation.","method":"ELL deletion mutant transfection, promoter-reporter assays, ChIP, zebrafish in vivo TSP-1 mRNA analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — domain mapping with mutagenesis, promoter assays, ChIP, and in vivo zebrafish confirmation","pmids":["19447890"],"is_preprint":false},{"year":2006,"finding":"ELL binding to U19/EAF2 is required for nuclear speckle formation of EAF2, stabilizes EAF2 protein, and enhances EAF2 transactivation activity.","method":"Co-transfection, co-immunoprecipitation, protein stability assay, transactivation assay","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in a single lab","pmids":["16114057"],"is_preprint":false},{"year":2010,"finding":"ELL associates with HIF-1alpha and inhibits HIF-1alpha protein levels and downstream gene expression in PC3 prostate cancer cells; hypoxia alleviates ELL-mediated inhibition of cell growth and colony formation.","method":"Co-localization, co-immunoprecipitation, stable ELL knockdown/overexpression with lentiviral system, Western blot, real-time PCR, cell growth and colony formation assays","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP with functional knockdown/overexpression validation, single lab","pmids":["20166137"],"is_preprint":false},{"year":2012,"finding":"ELL stabilizes RNA Pol II recruitment and initiation and promotes entry into the promoter-proximal pause site prior to assembly into the super elongation complex (SEC); loss of ELL destabilizes pre-initiation complexes and disrupts early elongation and promoter-proximal chromatin structure before AFF4 and other SEC components are recruited.","method":"ELL depletion, ChIP for Pol II and chromatin marks, kinetic analysis of transcription complex assembly, analysis of rapidly induced genes","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — ChIP-based mechanistic dissection with multiple orthogonal approaches showing temporal ELL function","pmids":["22252557"],"is_preprint":false},{"year":2013,"finding":"ELL is a partner of TFIIH and is recruited to UV-damaged chromatin in a Cdk7-dependent manner; ELL depletion strongly impairs RNA Pol II transcription resumption after DNA lesion repair and increases RNA Pol II retention on chromatin during the recovery period.","method":"Unbiased proteomic approach, ELL depletion by siRNA, UV irradiation, RNA Pol II ChIP and transcription restart assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — proteomic identification plus functional knockdown with defined molecular readout, multiple approaches","pmids":["24127601"],"is_preprint":false},{"year":2016,"finding":"ELL functions as an E3 ubiquitin ligase targeting c-Myc for proteasomal degradation; UbcH8 is the ubiquitin-conjugating enzyme (E2) in this pathway; Cysteine 595 of ELL is the active site, as C595A mutation abolishes c-Myc ubiquitination and degradation; ELL-mediated c-Myc degradation inhibits c-Myc-dependent transcription, cell proliferation, and xenograft tumor growth.","method":"In vitro ubiquitination assay, active-site mutagenesis (C595A), co-immunoprecipitation, proteasome inhibitor treatment, xenograft tumor model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — in vitro ubiquitination reconstitution plus active-site mutagenesis and in vivo tumor model","pmids":["27009366"],"is_preprint":false},{"year":2006,"finding":"S. pombe ELL ortholog (SpELL) forms a two-subunit complex with SpEAF that stimulates RNA polymerase II transcription elongation and pyrophosphorolysis; deletion of SpELL renders S. pombe sensitive to 6-azauracil, consistent with a role in elongation.","method":"Bioinformatic identification, biochemical purification, in vitro RNA polymerase II elongation and pyrophosphorolysis assays, drug sensitivity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assays plus genetic loss-of-function in fission yeast ortholog","pmids":["17150956"],"is_preprint":false},{"year":2011,"finding":"C. elegans ELL-1 and EAF-1 (worm orthologs) regulate fertility, survival, and body size; they modulate cuticle synthesis and control expression of collagen genes (dpy-3, dpy-13, sqt-3); ELL overexpression in PC3 human prostate cancer cells also regulates collagen gene expression.","method":"RNAi knockdown, eaf-1 mutant analysis, transgenic overexpression, collagen gene expression assays, cuticle structural analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — C. elegans loss-of-function with defined gene expression and structural phenotypes, validated in human cells","pmids":["21880729"],"is_preprint":false}],"current_model":"ELL is a multifunctional nuclear protein that primarily acts as an RNA polymerase II elongation factor by suppressing transient pausing and stabilizing Pol II at promoter-proximal pause sites before assembly into the super elongation complex (SEC); it also functions as an E3 ubiquitin ligase targeting c-Myc for proteasomal degradation, serves as a selective coactivator for the mineralocorticoid receptor, interacts with HIF-1α to modulate hypoxia responses, directly transactivates genes such as thrombospondin-1, participates in transcription restart after DNA repair via TFIIH interaction in a Cdk7-dependent manner, and when fused to MLL, drives acute myeloid leukemia through recruitment of EAF1-mediated transcriptional activation rather than through its elongation activity."},"narrative":{"teleology":[{"year":1994,"claim":"The identity of the gene at 19p13.1 disrupted in t(11;19) AML was unknown; cloning revealed ELL as a novel lysine-rich protein fused to MLL, establishing the first molecular link between this locus and leukemia.","evidence":"PCR cloning from patient leukemia cDNA library with Northern blot and evolutionary conservation analysis","pmids":["7991593"],"confidence":"High","gaps":["No functional activity was assigned to ELL at this point","The mechanism by which MLL-ELL drives leukemia was not addressed"]},{"year":1996,"claim":"The biochemical function of ELL was unknown; in vitro reconstitution demonstrated that ELL is an RNA Pol II elongation factor that increases the catalytic rate of transcription by suppressing transient pausing, establishing ELL's primary enzymatic activity.","evidence":"In vitro transcription elongation assay with purified components","pmids":["8596958"],"confidence":"High","gaps":["Mechanism of pause suppression at the nucleotide level was not resolved","In vivo relevance of the elongation activity was not demonstrated"]},{"year":1997,"claim":"ELL nuclear localization was confirmed and a paralog ELL2 with 49% identity and equivalent elongation activity was identified, establishing that ELL defines a conserved family of elongation factors with the N-terminal region as the elongation activation domain.","evidence":"Immunofluorescence across multiple cell lines; molecular cloning and in vitro elongation assay for ELL2","pmids":["9037066","9108030"],"confidence":"High","gaps":["Functional redundancy versus specificity between ELL and ELL2 was unresolved","ELL sub-nuclear compartmentalization was not yet characterized"]},{"year":1999,"claim":"It was unclear how ELL's activity on Pol II was regulated; identification of EAP30 as an ELL complex subunit that derepresses ELL's inhibitory effect on Pol II promoter-specific transcription revealed a built-in regulatory mechanism and a novel Pol II interaction domain in ELL.","evidence":"In vitro transcription reconstitution and protein interaction studies","pmids":["10419521"],"confidence":"High","gaps":["Full composition of the ELL complex was not determined","Whether AML translocations exploit this regulatory domain was not tested"]},{"year":2000,"claim":"Whether ELL's elongation activity was responsible for MLL-ELL leukemogenesis was unknown; structure-function analysis showed the C-terminal R4 domain (not the elongation domain) is necessary and sufficient for myeloid immortalization, establishing that MLL-ELL acts through transcriptional activation rather than elongation.","evidence":"Retroviral transduction of murine hematopoietic progenitors, serial replating assay, bone marrow transplantation, and transfection-based transcriptional assays with deletion mutants","pmids":["10995463","11090074"],"confidence":"High","gaps":["Target genes of MLL-ELL-mediated transcriptional activation were not identified genome-wide","How the R4 domain activates transcription molecularly was not defined"]},{"year":2001,"claim":"The molecular basis of ELL's pause-suppression activity was unclear; biochemical reconstitution showed ELL prevents displacement of the nascent RNA 3′ end from the Pol II catalytic site and inhibits SII-induced transcript cleavage, defining the elongation mechanism. Simultaneously, the EAF1-interaction domain of ELL was shown to be critical for MLL-ELL transformation, with MLL-EAF1 alone sufficient for AML, revealing EAF1 recruitment as the leukemogenic mechanism.","evidence":"In vitro transcription/cleavage assays with purified factors; structure-function mutagenesis with retroviral transduction and mouse bone marrow transplantation","pmids":["11259417","11463848"],"confidence":"High","gaps":["Whether EAF1's transactivation domain has specific cofactor partners was unknown","Structural basis of ELL-Pol II interaction was not determined"]},{"year":2002,"claim":"Whether ELL interacts with additional EAF family members was unknown; EAF2 was identified as a second ELL-interacting partner that colocalizes in nuclear speckles, with MLL-ELL selectively retaining EAF1 but not EAF2 interaction, suggesting differential complex assembly in normal versus leukemic states.","evidence":"Reciprocal co-immunoprecipitation, confocal microscopy, retroviral transformation assay","pmids":["12446457"],"confidence":"High","gaps":["Functional distinction between EAF1 and EAF2 in normal ELL biology was not resolved","Whether EAF2 loss contributes to leukemogenesis was not tested"]},{"year":2003,"claim":"The sub-nuclear compartment of ELL and consequences of MLL-ELL for nuclear organization were undefined; ELL and EAF1 were shown to reside in Cajal bodies in a Pol II transcription-dependent manner, and MLL-ELL leukemia cells exhibit disrupted Cajal bodies with delocalized coilin and EAF1. Separately, MLL-ELL was found to sequester and inhibit p53 via the ELL C-terminus, blocking p53 acetylation and p21 induction.","evidence":"Immunofluorescence colocalization with p80 coilin, pharmacological Pol II inhibition, confocal microscopy in leukemia cells; co-immunoprecipitation, p53 acetylation and apoptosis assays","pmids":["12686606","12773566"],"confidence":"High","gaps":["Whether Cajal body disruption is causally linked to leukemogenesis or a secondary consequence was not established","Whether wild-type ELL regulates p53 under physiological conditions was not tested"]},{"year":2005,"claim":"Whether ELL has roles beyond elongation was unclear; ELL was identified as a selective coactivator of the mineralocorticoid receptor that requires both its elongation and EAF1-interaction domains, extending ELL's function to steroid hormone signaling.","evidence":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, transcriptional assays with domain mutants","pmids":["15650021"],"confidence":"High","gaps":["Physiological significance of ELL-MR interaction in aldosterone-responsive tissues was not demonstrated","Whether ELL coactivation requires its Pol II elongation activity mechanistically was not dissected"]},{"year":2006,"claim":"Evolutionary conservation of ELL's elongation function was uncertain; the S. pombe ortholog SpELL was shown to form a two-subunit complex with SpEAF that stimulates Pol II elongation and pyrophosphorolysis, and its deletion causes 6-azauracil sensitivity, confirming deep conservation.","evidence":"Biochemical purification, in vitro elongation and pyrophosphorolysis assays, drug sensitivity assay in fission yeast","pmids":["17150956"],"confidence":"High","gaps":["Whether SpELL has functions beyond elongation analogous to mammalian ELL was not explored"]},{"year":2008,"claim":"In vivo evidence for ELL's role in transcriptional elongation at specific loci was lacking; Drosophila ELL was recruited to heat-shock loci upon induction, and its knockdown reduced phospho-Pol II levels at these loci, providing the first metazoan in vivo evidence that ELL is required for Pol II elongation at rapidly induced genes.","evidence":"RNAi in Drosophila, ChIP at heat shock loci, phospho-Pol II immunostaining","pmids":["18562276"],"confidence":"High","gaps":["Genome-wide scope of ELL-dependent elongation was not determined","Functional distinction from ELL2 in vivo was not resolved"]},{"year":2009,"claim":"Whether ELL acts as a direct DNA-binding transactivator was unknown; ELL was shown to bind the thrombospondin-1 promoter via its first 45 amino acids and transactivate TSP-1, with functional consequences for vasculogenesis in zebrafish, establishing a gene-specific transcriptional function distinct from general elongation.","evidence":"Deletion mutant transfection, promoter-reporter assays, ChIP, zebrafish in vivo analysis","pmids":["19447890"],"confidence":"High","gaps":["How many other genes are directly transactivated by ELL's DNA-binding domain was not determined","The DNA-binding mode and sequence specificity were not structurally resolved"]},{"year":2012,"claim":"ELL's temporal relationship to the super elongation complex was undefined; depletion experiments and kinetic ChIP analysis revealed that ELL stabilizes Pol II recruitment and entry into the promoter-proximal pause site before SEC assembly, placing ELL upstream of SEC in the transcription cycle.","evidence":"ELL depletion, ChIP for Pol II and chromatin marks, kinetic analysis of transcription complex assembly at rapidly induced genes","pmids":["22252557"],"confidence":"High","gaps":["How ELL is transferred from pre-SEC to SEC complexes was not resolved","Whether ELL's pre-SEC function is redundant with ELL2 was not tested"]},{"year":2013,"claim":"Whether ELL functions in DNA damage responses was unknown; ELL was identified as a TFIIH partner recruited to UV-damaged chromatin in a Cdk7-dependent manner, and its depletion severely impaired transcription restart after DNA repair, establishing a role for ELL in coupling DNA repair to transcription resumption.","evidence":"Unbiased proteomics, siRNA depletion, UV irradiation, Pol II ChIP and transcription restart assays","pmids":["24127601"],"confidence":"High","gaps":["Whether ELL's elongation activity is specifically required for restart or whether its presence suffices was not dissected","The mechanism of Cdk7-dependent ELL recruitment was not structurally resolved"]},{"year":2016,"claim":"ELL was not known to possess ubiquitin ligase activity; reconstitution revealed ELL functions as an E3 ubiquitin ligase targeting c-Myc for proteasomal degradation via UbcH8, with C595 as the catalytic cysteine, demonstrating a wholly unexpected enzymatic function with tumor-suppressive consequences.","evidence":"In vitro ubiquitination reconstitution, C595A active-site mutagenesis, co-immunoprecipitation, proteasome inhibitor treatment, xenograft tumor model","pmids":["27009366"],"confidence":"High","gaps":["Whether c-Myc is the sole substrate of ELL's E3 ligase activity was not determined","The structural basis for ELL's dual enzymatic activities (elongation and E3 ligase) was not resolved","Independent replication of the E3 ligase activity has not been reported"]},{"year":null,"claim":"How ELL coordinates its multiple activities — elongation factor, E3 ubiquitin ligase, DNA-binding transactivator, and nuclear receptor coactivator — within the same protein, and whether these represent context-dependent or simultaneously active functions, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of full-length ELL exists","Genome-wide identification of direct ELL DNA-binding targets has not been performed","Whether ELL's E3 ligase activity operates in the context of its elongation complexes is unknown","Functional redundancy with ELL2 and ELL3 in mammalian systems has not been systematically addressed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,5,7,13,17,20]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[19]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[19]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,12,14]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[14]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,11]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[8,9]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,7,17,20]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,2,4]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[19]}],"complexes":["Super Elongation Complex (SEC)","ELL-EAF1 complex","ELL-EAF2 complex","ELL-EAP30 complex"],"partners":["EAF1","EAF2","EAP30","TFIIH","MLL","AFF4","NR3C2","HIF1A"],"other_free_text":[]},"mechanistic_narrative":"ELL is an evolutionarily conserved RNA polymerase II elongation factor that suppresses transient pausing by preventing displacement of nascent transcripts from the polymerase catalytic site, stabilizes Pol II at promoter-proximal pause sites prior to assembly into the super elongation complex (SEC), and participates in transcription restart after UV-induced DNA damage through Cdk7-dependent recruitment via TFIIH [PMID:8596958, PMID:11259417, PMID:22252557, PMID:24127601]. Beyond its elongation function, ELL acts as an E3 ubiquitin ligase that targets c-Myc for UbcH8-dependent proteasomal degradation through an active-site cysteine (C595), thereby inhibiting c-Myc-dependent proliferation, and additionally serves as a selective coactivator of the mineralocorticoid receptor and a direct DNA-binding transactivator of genes such as thrombospondin-1 [PMID:27009366, PMID:15650021, PMID:19447890]. ELL was identified as the gene fused to MLL in the t(11;19)(q23;p13.1) translocation that causes acute myeloid leukemia; leukemogenic transformation depends not on ELL's elongation domain but on its C-terminal domain that recruits the transcriptional coactivator EAF1 [PMID:7991593, PMID:11090074, PMID:11463848]. ELL and its associated factors EAF1/EAF2 localize to Cajal bodies and nuclear speckles in a transcription-dependent manner, and MLL-ELL disrupts these nuclear structures while also sequestering and inhibiting p53 [PMID:12686606, PMID:12446457, PMID:12773566]."},"prefetch_data":{"uniprot":{"accession":"P55199","full_name":"RNA polymerase II elongation factor ELL","aliases":["Eleven-nineteen lysine-rich leukemia protein"],"length_aa":621,"mass_kda":68.3,"function":"Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Elongation factor component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968, PubMed:23932780). Specifically required for stimulating the elongation step of RNA polymerase II- and III-dependent snRNA gene transcription (PubMed:23932780). ELL also plays an early role before its assembly into in the SEC complex by stabilizing RNA polymerase II recruitment/initiation and entry into the pause site. Required to stabilize the pre-initiation complex and early elongation","subcellular_location":"Nucleus; Nucleus speckle; Nucleus, Cajal body","url":"https://www.uniprot.org/uniprotkb/P55199/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ELL","classification":"Common Essential","n_dependent_lines":1147,"n_total_lines":1208,"dependency_fraction":0.9495033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ELL","total_profiled":1310},"omim":[{"mim_id":"617958","title":"INTERACTOR OF LITTLE ELONGATION COMPLEX ELL SUBUNIT 1; ICE1","url":"https://www.omim.org/entry/617958"},{"mim_id":"617470","title":"UBIQUITIN-SPECIFIC PEPTIDASE-LIKE 1; USPL1","url":"https://www.omim.org/entry/617470"},{"mim_id":"610907","title":"VACUOLAR PROTEIN SORTING 25 HOMOLOG; VPS25","url":"https://www.omim.org/entry/610907"},{"mim_id":"610904","title":"SNF8 SUBUNIT OF ESCRIT-II; SNF8","url":"https://www.omim.org/entry/610904"},{"mim_id":"610903","title":"VACUOLAR PROTEIN SORTING 36 HOMOLOG; VPS36","url":"https://www.omim.org/entry/610903"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ELL"},"hgnc":{"alias_symbol":["Men","ELL1","PPP1R68"],"prev_symbol":["C19orf17"]},"alphafold":{"accession":"P55199","domains":[{"cath_id":"-","chopping":"27-134","consensus_level":"high","plddt":85.3538,"start":27,"end":134},{"cath_id":"1.10.10.2670","chopping":"208-293","consensus_level":"high","plddt":89.6044,"start":208,"end":293},{"cath_id":"-","chopping":"514-620","consensus_level":"high","plddt":93.9492,"start":514,"end":620}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P55199","model_url":"https://alphafold.ebi.ac.uk/files/AF-P55199-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P55199-F1-predicted_aligned_error_v6.png","plddt_mean":67.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ELL","jax_strain_url":"https://www.jax.org/strain/search?query=ELL"},"sequence":{"accession":"P55199","fasta_url":"https://rest.uniprot.org/uniprotkb/P55199.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P55199/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P55199"}},"corpus_meta":[{"pmid":"16551248","id":"PMC_16551248","title":"FOXP3: of mice and men.","date":"2006","source":"Annual review of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16551248","citation_count":766,"is_preprint":false},{"pmid":"27664823","id":"PMC_27664823","title":"The role of masculinity in men's help-seeking for depression: A systematic review.","date":"2016","source":"Clinical psychology review","url":"https://pubmed.ncbi.nlm.nih.gov/27664823","citation_count":568,"is_preprint":false},{"pmid":"9147109","id":"PMC_9147109","title":"Cytogenetics of infertile men.","date":"1996","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9147109","citation_count":343,"is_preprint":false},{"pmid":"12379069","id":"PMC_12379069","title":"Breast cancer in men.","date":"2002","source":"Annals of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12379069","citation_count":315,"is_preprint":false},{"pmid":"6605701","id":"PMC_6605701","title":"Generalized lymphadenopathy in homosexual men.","date":"1983","source":"Annals of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/6605701","citation_count":305,"is_preprint":false},{"pmid":"8596958","id":"PMC_8596958","title":"An RNA polymerase II elongation factor encoded by the human ELL gene.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8596958","citation_count":297,"is_preprint":false},{"pmid":"7991593","id":"PMC_7991593","title":"Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7991593","citation_count":207,"is_preprint":false},{"pmid":"18923135","id":"PMC_18923135","title":"Idiopathic intracranial hypertension in men.","date":"2008","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18923135","citation_count":168,"is_preprint":false},{"pmid":"16403409","id":"PMC_16403409","title":"Conditional expression of women's desires and men's mate guarding across the ovulatory cycle.","date":"2006","source":"Hormones and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/16403409","citation_count":155,"is_preprint":false},{"pmid":"29641964","id":"PMC_29641964","title":"Zika Virus Shedding in Semen of Symptomatic Infected Men.","date":"2018","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29641964","citation_count":154,"is_preprint":false},{"pmid":"15669543","id":"PMC_15669543","title":"Progesterone: the forgotten hormone in men?","date":"2004","source":"The aging male : the official journal of the International Society for the Study of the Aging Male","url":"https://pubmed.ncbi.nlm.nih.gov/15669543","citation_count":151,"is_preprint":false},{"pmid":"25733578","id":"PMC_25733578","title":"Cohort Profile: The Shanghai Men's Health Study.","date":"2015","source":"International journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/25733578","citation_count":139,"is_preprint":false},{"pmid":"9403124","id":"PMC_9403124","title":"Declining gonadal function in elderly men.","date":"1997","source":"Bailliere's clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9403124","citation_count":124,"is_preprint":false},{"pmid":"10995463","id":"PMC_10995463","title":"Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10995463","citation_count":120,"is_preprint":false},{"pmid":"10374090","id":"PMC_10374090","title":"Genetic evaluation of infertile men.","date":"1999","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10374090","citation_count":118,"is_preprint":false},{"pmid":"28536242","id":"PMC_28536242","title":"Mutation in TDRD9 causes non-obstructive azoospermia in infertile men.","date":"2017","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28536242","citation_count":116,"is_preprint":false},{"pmid":"2494289","id":"PMC_2494289","title":"Serum inhibin levels in normal men and men with testicular disorders.","date":"1989","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2494289","citation_count":115,"is_preprint":false},{"pmid":"16792526","id":"PMC_16792526","title":"In control of biology: of mice, men and Foxes.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16792526","citation_count":113,"is_preprint":false},{"pmid":"7757495","id":"PMC_7757495","title":"Brain spectrin: of mice and men.","date":"1995","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/7757495","citation_count":112,"is_preprint":false},{"pmid":"9108030","id":"PMC_9108030","title":"ELL2, a new member of an ELL family of RNA polymerase II elongation factors.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9108030","citation_count":111,"is_preprint":false},{"pmid":"35504878","id":"PMC_35504878","title":"High-throughput single-сell sequencing in cancer research.","date":"2022","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35504878","citation_count":109,"is_preprint":false},{"pmid":"12045493","id":"PMC_12045493","title":"HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men.","date":"2002","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12045493","citation_count":106,"is_preprint":false},{"pmid":"15385442","id":"PMC_15385442","title":"Defective recombination in infertile men.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15385442","citation_count":104,"is_preprint":false},{"pmid":"17907857","id":"PMC_17907857","title":"Multivariate models of men's and women's partner aggression.","date":"2007","source":"Journal of consulting and clinical psychology","url":"https://pubmed.ncbi.nlm.nih.gov/17907857","citation_count":97,"is_preprint":false},{"pmid":"11573703","id":"PMC_11573703","title":"Cardiac arrhythmias: from (transgenic) mice to men.","date":"2001","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/11573703","citation_count":95,"is_preprint":false},{"pmid":"28853720","id":"PMC_28853720","title":"The Y chromosome: a blueprint for men's health?","date":"2017","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/28853720","citation_count":93,"is_preprint":false},{"pmid":"7938171","id":"PMC_7938171","title":"Pax: genes for mice and men.","date":"1994","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/7938171","citation_count":90,"is_preprint":false},{"pmid":"11090074","id":"PMC_11090074","title":"A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11090074","citation_count":88,"is_preprint":false},{"pmid":"21123766","id":"PMC_21123766","title":"Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21123766","citation_count":85,"is_preprint":false},{"pmid":"11463848","id":"PMC_11463848","title":"The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11463848","citation_count":81,"is_preprint":false},{"pmid":"11756356","id":"PMC_11756356","title":"Screening for Y chromosome microdeletions in 226 Slovenian subfertile men.","date":"2002","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11756356","citation_count":76,"is_preprint":false},{"pmid":"12446457","id":"PMC_12446457","title":"ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12446457","citation_count":72,"is_preprint":false},{"pmid":"25315188","id":"PMC_25315188","title":"Androgen receptor signaling regulates growth of glioblastoma multiforme in men.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25315188","citation_count":71,"is_preprint":false},{"pmid":"19836146","id":"PMC_19836146","title":"The human superorganism - of microbes and men.","date":"2010","source":"Medical hypotheses","url":"https://pubmed.ncbi.nlm.nih.gov/19836146","citation_count":70,"is_preprint":false},{"pmid":"15711018","id":"PMC_15711018","title":"Diabetic cardiomyopathy: do women differ from men?","date":"2004","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/15711018","citation_count":70,"is_preprint":false},{"pmid":"15650021","id":"PMC_15650021","title":"The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.","date":"2005","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15650021","citation_count":67,"is_preprint":false},{"pmid":"27359067","id":"PMC_27359067","title":"Systems analysis of the prostate transcriptome in African-American men compared with European-American men.","date":"2016","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/27359067","citation_count":64,"is_preprint":false},{"pmid":"19140019","id":"PMC_19140019","title":"Myofilament dysfunction in cardiac disease from mice to men.","date":"2009","source":"Journal of muscle research and cell motility","url":"https://pubmed.ncbi.nlm.nih.gov/19140019","citation_count":64,"is_preprint":false},{"pmid":"12668350","id":"PMC_12668350","title":"The genes and brains of mice and men.","date":"2003","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12668350","citation_count":63,"is_preprint":false},{"pmid":"22189712","id":"PMC_22189712","title":"The power of MEN in cytokinesis.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22189712","citation_count":58,"is_preprint":false},{"pmid":"19154724","id":"PMC_19154724","title":"Cell polarity determinants establish asymmetry in MEN signaling.","date":"2009","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/19154724","citation_count":56,"is_preprint":false},{"pmid":"6499362","id":"PMC_6499362","title":"Prednisolone disposition in obese men.","date":"1984","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/6499362","citation_count":52,"is_preprint":false},{"pmid":"19995647","id":"PMC_19995647","title":"Differential expression of biomarkers in men and women.","date":"2009","source":"Seminars in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19995647","citation_count":48,"is_preprint":false},{"pmid":"11228931","id":"PMC_11228931","title":"Differences in reproductive endocrinology between Asian men and Caucasian men--a literature review.","date":"2000","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/11228931","citation_count":46,"is_preprint":false},{"pmid":"36506029","id":"PMC_36506029","title":"Prevention and treatment of human papillomavirus in men benefits both men and women.","date":"2022","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36506029","citation_count":44,"is_preprint":false},{"pmid":"24337010","id":"PMC_24337010","title":"Functional consequences of EpCam mutation in mice and men.","date":"2013","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24337010","citation_count":44,"is_preprint":false},{"pmid":"24127601","id":"PMC_24127601","title":"ELL, a novel TFIIH partner, is involved in transcription restart after DNA repair.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24127601","citation_count":44,"is_preprint":false},{"pmid":"23212543","id":"PMC_23212543","title":"WNT signaling and cartilage: of mice and men.","date":"2012","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/23212543","citation_count":43,"is_preprint":false},{"pmid":"29673272","id":"PMC_29673272","title":"Critical Issues in Men's Mental Health.","date":"2018","source":"Canadian journal of psychiatry. Revue canadienne de psychiatrie","url":"https://pubmed.ncbi.nlm.nih.gov/29673272","citation_count":42,"is_preprint":false},{"pmid":"22252557","id":"PMC_22252557","title":"ELL facilitates RNA polymerase II pause site entry and release.","date":"2012","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/22252557","citation_count":42,"is_preprint":false},{"pmid":"15114471","id":"PMC_15114471","title":"Control of glycaemia: from molecules to men. Minkowski Lecture 2003.","date":"2004","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/15114471","citation_count":41,"is_preprint":false},{"pmid":"2478611","id":"PMC_2478611","title":"Of matrices and men.","date":"1989","source":"Journal of biochemical and biophysical methods","url":"https://pubmed.ncbi.nlm.nih.gov/2478611","citation_count":39,"is_preprint":false},{"pmid":"12686606","id":"PMC_12686606","title":"ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12686606","citation_count":38,"is_preprint":false},{"pmid":"27009366","id":"PMC_27009366","title":"ELL targets c-Myc for proteasomal degradation and suppresses tumour growth.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27009366","citation_count":37,"is_preprint":false},{"pmid":"18562276","id":"PMC_18562276","title":"Regulation of the transcriptional activity of poised RNA polymerase II by the elongation factor ELL.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18562276","citation_count":37,"is_preprint":false},{"pmid":"12874608","id":"PMC_12874608","title":"Sexual activity in hypertensive men.","date":"2003","source":"Journal of human hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/12874608","citation_count":37,"is_preprint":false},{"pmid":"25204357","id":"PMC_25204357","title":"The impact of prostate cancer on men's everyday life.","date":"2014","source":"European journal of cancer care","url":"https://pubmed.ncbi.nlm.nih.gov/25204357","citation_count":37,"is_preprint":false},{"pmid":"12773566","id":"PMC_12773566","title":"Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12773566","citation_count":35,"is_preprint":false},{"pmid":"10419521","id":"PMC_10419521","title":"Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10419521","citation_count":35,"is_preprint":false},{"pmid":"2399296","id":"PMC_2399296","title":"Anxiety and food intake in men.","date":"1990","source":"Psychosomatic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2399296","citation_count":35,"is_preprint":false},{"pmid":"11259417","id":"PMC_11259417","title":"Transcription factors TFIIF, ELL, and Elongin negatively regulate SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11259417","citation_count":34,"is_preprint":false},{"pmid":"22088127","id":"PMC_22088127","title":"Banking sperm is only the first of many decisions for men: what healthcare professionals and men need to know.","date":"2011","source":"Human fertility (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22088127","citation_count":33,"is_preprint":false},{"pmid":"18927127","id":"PMC_18927127","title":"USP26 gene variations in fertile and infertile men.","date":"2008","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18927127","citation_count":32,"is_preprint":false},{"pmid":"7655733","id":"PMC_7655733","title":"Multiple endocrine neoplasia type 1 (MEN 1) revisited.","date":"1995","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/7655733","citation_count":32,"is_preprint":false},{"pmid":"15165898","id":"PMC_15165898","title":"Of flies and men; p53, a tumour suppressor.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15165898","citation_count":31,"is_preprint":false},{"pmid":"16443584","id":"PMC_16443584","title":"Cytogenetic analyses in infertile men.","date":"2006","source":"Archives of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/16443584","citation_count":31,"is_preprint":false},{"pmid":"19340391","id":"PMC_19340391","title":"Anxiety in mice and men: a comparison.","date":"2009","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/19340391","citation_count":30,"is_preprint":false},{"pmid":"24931355","id":"PMC_24931355","title":"Multiple endocrine neoplasia (MEN) syndromes.","date":"2014","source":"Seminars in pediatric surgery","url":"https://pubmed.ncbi.nlm.nih.gov/24931355","citation_count":29,"is_preprint":false},{"pmid":"21880729","id":"PMC_21880729","title":"Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21880729","citation_count":29,"is_preprint":false},{"pmid":"23645088","id":"PMC_23645088","title":"Mitochondrial DNA mutations and polymorphisms in asthenospermic infertile men.","date":"2013","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23645088","citation_count":28,"is_preprint":false},{"pmid":"10849016","id":"PMC_10849016","title":"Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding.","date":"2000","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10849016","citation_count":28,"is_preprint":false},{"pmid":"30565412","id":"PMC_30565412","title":"Normobaric hypoxic conditioning in men with metabolic syndrome.","date":"2018","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/30565412","citation_count":28,"is_preprint":false},{"pmid":"9866208","id":"PMC_9866208","title":"Y chromosome variation of mice and men.","date":"1998","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/9866208","citation_count":26,"is_preprint":false},{"pmid":"25532417","id":"PMC_25532417","title":"Insulin resistance and depressive symptoms in older men: the health in men study.","date":"2014","source":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25532417","citation_count":26,"is_preprint":false},{"pmid":"23582559","id":"PMC_23582559","title":"Effects of intermittent fasting on metabolism in men.","date":"2013","source":"Revista da Associacao Medica Brasileira (1992)","url":"https://pubmed.ncbi.nlm.nih.gov/23582559","citation_count":25,"is_preprint":false},{"pmid":"19447890","id":"PMC_19447890","title":"Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19447890","citation_count":25,"is_preprint":false},{"pmid":"17150956","id":"PMC_17150956","title":"Identification and Characterization of a Schizosaccharomyces pombe RNA Polymerase II Elongation Factor with Similarity to the Metazoan Transcription Factor ELL.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17150956","citation_count":25,"is_preprint":false},{"pmid":"24696767","id":"PMC_24696767","title":"Chromosomal abnormality in men with impaired spermatogenesis.","date":"2014","source":"International journal of fertility & sterility","url":"https://pubmed.ncbi.nlm.nih.gov/24696767","citation_count":25,"is_preprint":false},{"pmid":"18681990","id":"PMC_18681990","title":"Altered expression of progesterone receptors in testis of infertile men.","date":"2008","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/18681990","citation_count":25,"is_preprint":false},{"pmid":"36231089","id":"PMC_36231089","title":"Of Flies and Men-The Discovery of TLRs.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36231089","citation_count":24,"is_preprint":false},{"pmid":"9037066","id":"PMC_9037066","title":"Developmental analysis and subcellular localization of the murine homologue of ELL.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9037066","citation_count":23,"is_preprint":false},{"pmid":"30202739","id":"PMC_30202739","title":"What should be done for men with sperm DNA fragmentation?","date":"2018","source":"Clinical and experimental reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30202739","citation_count":22,"is_preprint":false},{"pmid":"14517999","id":"PMC_14517999","title":"Expression of murine ELL-associated factor 2 (Eaf2) is developmentally regulated.","date":"2003","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/14517999","citation_count":21,"is_preprint":false},{"pmid":"29972105","id":"PMC_29972105","title":"Neuropsychiatric Aspects in Men with Klinefelter Syndrome.","date":"2019","source":"Endocrine, metabolic & immune disorders drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/29972105","citation_count":21,"is_preprint":false},{"pmid":"26393143","id":"PMC_26393143","title":"Chromosomal Abnormalities in Infertile Men from Southern India.","date":"2015","source":"Journal of clinical and diagnostic research : JCDR","url":"https://pubmed.ncbi.nlm.nih.gov/26393143","citation_count":21,"is_preprint":false},{"pmid":"30626059","id":"PMC_30626059","title":"Bisphenol A Exposure and Sperm ACHE Hydroxymethylation in Men.","date":"2019","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/30626059","citation_count":21,"is_preprint":false},{"pmid":"19272337","id":"PMC_19272337","title":"Gene doping: of mice and men.","date":"2009","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19272337","citation_count":20,"is_preprint":false},{"pmid":"29459712","id":"PMC_29459712","title":"The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29459712","citation_count":19,"is_preprint":false},{"pmid":"30884051","id":"PMC_30884051","title":"Testosterone-dependent facial and body traits predict men's sociosexual attitudes and behaviors.","date":"2019","source":"American journal of human biology : the official journal of the Human Biology Council","url":"https://pubmed.ncbi.nlm.nih.gov/30884051","citation_count":19,"is_preprint":false},{"pmid":"12801560","id":"PMC_12801560","title":"Y chromosome microdeletions in infertile men with cryptorchidism.","date":"2003","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/12801560","citation_count":19,"is_preprint":false},{"pmid":"17243571","id":"PMC_17243571","title":"Of mice and men: teratomas and teratocarcinomas.","date":"2006","source":"Collegium antropologicum","url":"https://pubmed.ncbi.nlm.nih.gov/17243571","citation_count":19,"is_preprint":false},{"pmid":"31412971","id":"PMC_31412971","title":"MicroRNA expression in infertile men: its alterations and effects.","date":"2019","source":"Zygote (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31412971","citation_count":18,"is_preprint":false},{"pmid":"20483870","id":"PMC_20483870","title":"Aging men and lipids.","date":"2010","source":"American journal of men's health","url":"https://pubmed.ncbi.nlm.nih.gov/20483870","citation_count":18,"is_preprint":false},{"pmid":"17824171","id":"PMC_17824171","title":"Of mice and men: the many guises of estrogens.","date":"2006","source":"Ernst Schering Foundation symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/17824171","citation_count":18,"is_preprint":false},{"pmid":"16114057","id":"PMC_16114057","title":"ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.","date":"2006","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/16114057","citation_count":18,"is_preprint":false},{"pmid":"21825313","id":"PMC_21825313","title":"Postnatal neurogenesis: of mice, men, and macaques.","date":"2011","source":"Veterinary pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21825313","citation_count":17,"is_preprint":false},{"pmid":"34168527","id":"PMC_34168527","title":"The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health.","date":"2021","source":"Current urology","url":"https://pubmed.ncbi.nlm.nih.gov/34168527","citation_count":16,"is_preprint":false},{"pmid":"24089521","id":"PMC_24089521","title":"The leukemia-associated Mll-Ell oncoprotein induces fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24089521","citation_count":16,"is_preprint":false},{"pmid":"27110078","id":"PMC_27110078","title":"Antisperm protein targets in azoospermia men.","date":"2016","source":"Journal of human reproductive sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27110078","citation_count":15,"is_preprint":false},{"pmid":"20166137","id":"PMC_20166137","title":"ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.","date":"2010","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/20166137","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42669,"output_tokens":4936,"usd":0.101024},"stage2":{"model":"claude-opus-4-6","input_tokens":8473,"output_tokens":4149,"usd":0.219135},"total_usd":0.320159,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"ELL encodes an RNA polymerase II elongation factor that increases the catalytic rate of transcription by suppressing transient pausing by RNA polymerase II at multiple sites along DNA templates.\",\n      \"method\": \"In vitro transcription elongation assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro biochemical assay establishing enzymatic mechanism, foundational paper with >297 citations\",\n      \"pmids\": [\"8596958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"ELL (eleven-nineteen lysine-rich leukemia) was identified as the gene fusing to MLL in the t(11;19)(q23;p13.1) translocation in acute myeloid leukemia; predicted protein contains a highly basic, lysine-rich motif homologous to the DNA-binding domain of poly(ADP-ribose) polymerase.\",\n      \"method\": \"PCR cloning from patient leukemia cDNA library, Northern blot, zoo blot evolutionary conservation analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — molecular cloning with multiple orthogonal methods, foundational identification paper\",\n      \"pmids\": [\"7991593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MLL-ELL fusion protein immortalizes myeloid progenitors and causes acute myeloid leukemia in mice; ELL alone has no transforming effect, establishing that MLL fusion drives oncogenesis.\",\n      \"method\": \"Retroviral transduction of murine hematopoietic progenitors, serial replating assay, bone marrow transplantation into lethally irradiated mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean in vivo mouse model with defined phenotypic readout, replicated across 20 animals\",\n      \"pmids\": [\"10995463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The carboxy-terminal R4 domain of ELL (not the elongation domain) is both necessary and sufficient for MLL-ELL-mediated immortalization of myeloid progenitors; the R4 domain has potent transcriptional activation properties and transactivates a HoxA7 promoter.\",\n      \"method\": \"Structure-function analysis with truncation/deletion mutants, retroviral transduction serial replating assay, transient transfection transcriptional assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with functional cellular and transcriptional assays\",\n      \"pmids\": [\"11090074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The EAF1 interaction domain of ELL (not the elongation domain) is critical for MLL-ELL-mediated leukemogenic transformation; MLL-EAF1 fusion alone is sufficient to immortalize myeloid progenitors and induce AML in vivo, suggesting recruitment of an EAF1-like transactivation domain is a common mechanism of 11q23 leukemogenesis.\",\n      \"method\": \"Structure-function analysis of MLL-ELL mutants, retroviral bone marrow transduction, in vitro transformation assay, mouse bone marrow transplantation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis with in vitro and in vivo confirmation, multiple orthogonal approaches\",\n      \"pmids\": [\"11463848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"ELL2 is a novel RNA polymerase II elongation factor 49% identical to ELL; ELL2 and ELL possess similar transcriptional elongation activities; the elongation activation domain maps to the N-terminal region of ELL2 that is highly homologous to ELL.\",\n      \"method\": \"Molecular cloning, in vitro transcription elongation assay, Northern blot, structure-function analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro elongation assay with domain mapping, directly characterizing ELL family mechanism\",\n      \"pmids\": [\"9108030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"EAP30 subunit of the ELL complex interacts with ELL and derepresses ELL's inhibitory activity on RNA polymerase II promoter-specific transcription in vitro; ELL has a novel RNA polymerase II interaction domain capable of repressing polymerase activity, which is deleted in AML translocations.\",\n      \"method\": \"In vitro transcription assay, protein interaction studies, sequence homology to S. cerevisiae SNF8\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution establishing derepression mechanism\",\n      \"pmids\": [\"10419521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ELL (along with TFIIF and Elongin) suppresses transient pausing by RNA polymerase II by preventing displacement of the 3′ end of the nascent transcript from the polymerase catalytic site, and inhibits SII-induced nascent transcript cleavage by non-arrested RNA polymerase II elongation intermediates.\",\n      \"method\": \"In vitro transcription and nascent transcript cleavage assays with purified factors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mechanistic dissection of elongation versus cleavage activities\",\n      \"pmids\": [\"11259417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"EAF2 (ELL Associated Factor 2) physically interacts with ELL via an amino-terminal interaction domain of ELL; ELL and EAF2 colocalize in a nuclear speckled pattern; EAF2 contains a transcriptional activation domain; MLL-ELL disrupts normal ELL protein-protein interactions by retaining EAF1 but not EAF2 interaction.\",\n      \"method\": \"Co-immunoprecipitation with specific antibodies, confocal microscopy, retroviral bone marrow transduction transformation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, co-localization, and functional transformation assay, multiple orthogonal methods\",\n      \"pmids\": [\"12446457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ELL and EAF1 are components of Cajal bodies (CBs); their localization in CBs is dependent on active RNA polymerase II transcription (dispersed by actinomycin D, DRB, or alpha-amanitin); CBs are disrupted in MLL-ELL leukemia cells with delocalization of EAF1 and p80 coilin.\",\n      \"method\": \"Immunofluorescence colocalization with p80 coilin, pharmacological inhibition of Pol II, nuclear/cytoplasmic fractionation, confocal microscopy in MLL-ELL leukemia cells\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence via transcription inhibition and leukemia cell comparison\",\n      \"pmids\": [\"12686606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MLL-ELL inhibits p53 functional activity more efficiently than wild-type ELL; the extreme C-terminus of ELL (ELL eCT) recruits p53 into MLL-ELL nuclear foci and is necessary and sufficient for MLL-ELL inhibition of p53-mediated p21 induction and apoptosis; MLL-ELL disrupts p53 interactions with p300/CBP and reduces p53 acetylation in vivo.\",\n      \"method\": \"Transient transfection, co-immunoprecipitation, p53 acetylation assay, apoptosis assay, p21 induction assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including protein interaction, PTM analysis, and functional readouts\",\n      \"pmids\": [\"12773566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Murine ELL protein localizes to the nucleus but is excluded from nucleoli in multiple cell lines (COS-7, HeLa, NIH 3T3, A7r5), consistent with its function as an RNA polymerase II elongation factor.\",\n      \"method\": \"Immunofluorescence with polyclonal antiserum to ELL, subcellular localization in multiple cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment across multiple cell lines, single lab\",\n      \"pmids\": [\"9037066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ELL physically interacts with the mineralocorticoid receptor (MR) N-terminal domain and acts as a selective coactivator of MR; ELL differentially modulates steroid receptor responses with opposite effects on MR versus glucocorticoid receptor, without affecting androgen or progesterone receptors; both the elongation domain and EAF1 interaction domain are required for ELL's coactivator function.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, transient transfection transcriptional assays with deletion/point mutants\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including pulldown, Co-IP, mutagenesis, and transcriptional assays\",\n      \"pmids\": [\"15650021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Drosophila ELL (dELL) is recruited to heat shock loci upon induction and is required for proper heat-shock gene expression; dELL knockdown reduces levels of phosphorylated (elongating) RNA Pol II at heat-shock loci; dELL and its associated factor dEaf are both essential for fly development.\",\n      \"method\": \"RNAi knockdown in Drosophila, chromatin immunoprecipitation at heat shock loci, phospho-Pol II immunostaining\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — RNAi loss-of-function with ChIP and molecular phenotype in a metazoan model organism\",\n      \"pmids\": [\"18562276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ELL directly binds to the thrombospondin-1 (TSP-1) promoter and transactivates TSP-1 gene expression; DNA binding maps to the first 45 amino acids of ELL; the ELL response element maps to -1426 to -1418 of the TSP-1 promoter; MLL-ELL (lacking the N-terminal 45 aa) cannot induce TSP-1; ELL inhibits zebrafish vasculogenesis in part through TSP-1 upregulation.\",\n      \"method\": \"ELL deletion mutant transfection, promoter-reporter assays, ChIP, zebrafish in vivo TSP-1 mRNA analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — domain mapping with mutagenesis, promoter assays, ChIP, and in vivo zebrafish confirmation\",\n      \"pmids\": [\"19447890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ELL binding to U19/EAF2 is required for nuclear speckle formation of EAF2, stabilizes EAF2 protein, and enhances EAF2 transactivation activity.\",\n      \"method\": \"Co-transfection, co-immunoprecipitation, protein stability assay, transactivation assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in a single lab\",\n      \"pmids\": [\"16114057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ELL associates with HIF-1alpha and inhibits HIF-1alpha protein levels and downstream gene expression in PC3 prostate cancer cells; hypoxia alleviates ELL-mediated inhibition of cell growth and colony formation.\",\n      \"method\": \"Co-localization, co-immunoprecipitation, stable ELL knockdown/overexpression with lentiviral system, Western blot, real-time PCR, cell growth and colony formation assays\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with functional knockdown/overexpression validation, single lab\",\n      \"pmids\": [\"20166137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ELL stabilizes RNA Pol II recruitment and initiation and promotes entry into the promoter-proximal pause site prior to assembly into the super elongation complex (SEC); loss of ELL destabilizes pre-initiation complexes and disrupts early elongation and promoter-proximal chromatin structure before AFF4 and other SEC components are recruited.\",\n      \"method\": \"ELL depletion, ChIP for Pol II and chromatin marks, kinetic analysis of transcription complex assembly, analysis of rapidly induced genes\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based mechanistic dissection with multiple orthogonal approaches showing temporal ELL function\",\n      \"pmids\": [\"22252557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ELL is a partner of TFIIH and is recruited to UV-damaged chromatin in a Cdk7-dependent manner; ELL depletion strongly impairs RNA Pol II transcription resumption after DNA lesion repair and increases RNA Pol II retention on chromatin during the recovery period.\",\n      \"method\": \"Unbiased proteomic approach, ELL depletion by siRNA, UV irradiation, RNA Pol II ChIP and transcription restart assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proteomic identification plus functional knockdown with defined molecular readout, multiple approaches\",\n      \"pmids\": [\"24127601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ELL functions as an E3 ubiquitin ligase targeting c-Myc for proteasomal degradation; UbcH8 is the ubiquitin-conjugating enzyme (E2) in this pathway; Cysteine 595 of ELL is the active site, as C595A mutation abolishes c-Myc ubiquitination and degradation; ELL-mediated c-Myc degradation inhibits c-Myc-dependent transcription, cell proliferation, and xenograft tumor growth.\",\n      \"method\": \"In vitro ubiquitination assay, active-site mutagenesis (C595A), co-immunoprecipitation, proteasome inhibitor treatment, xenograft tumor model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro ubiquitination reconstitution plus active-site mutagenesis and in vivo tumor model\",\n      \"pmids\": [\"27009366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"S. pombe ELL ortholog (SpELL) forms a two-subunit complex with SpEAF that stimulates RNA polymerase II transcription elongation and pyrophosphorolysis; deletion of SpELL renders S. pombe sensitive to 6-azauracil, consistent with a role in elongation.\",\n      \"method\": \"Bioinformatic identification, biochemical purification, in vitro RNA polymerase II elongation and pyrophosphorolysis assays, drug sensitivity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assays plus genetic loss-of-function in fission yeast ortholog\",\n      \"pmids\": [\"17150956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"C. elegans ELL-1 and EAF-1 (worm orthologs) regulate fertility, survival, and body size; they modulate cuticle synthesis and control expression of collagen genes (dpy-3, dpy-13, sqt-3); ELL overexpression in PC3 human prostate cancer cells also regulates collagen gene expression.\",\n      \"method\": \"RNAi knockdown, eaf-1 mutant analysis, transgenic overexpression, collagen gene expression assays, cuticle structural analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — C. elegans loss-of-function with defined gene expression and structural phenotypes, validated in human cells\",\n      \"pmids\": [\"21880729\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ELL is a multifunctional nuclear protein that primarily acts as an RNA polymerase II elongation factor by suppressing transient pausing and stabilizing Pol II at promoter-proximal pause sites before assembly into the super elongation complex (SEC); it also functions as an E3 ubiquitin ligase targeting c-Myc for proteasomal degradation, serves as a selective coactivator for the mineralocorticoid receptor, interacts with HIF-1α to modulate hypoxia responses, directly transactivates genes such as thrombospondin-1, participates in transcription restart after DNA repair via TFIIH interaction in a Cdk7-dependent manner, and when fused to MLL, drives acute myeloid leukemia through recruitment of EAF1-mediated transcriptional activation rather than through its elongation activity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ELL is an evolutionarily conserved RNA polymerase II elongation factor that suppresses transient pausing by preventing displacement of nascent transcripts from the polymerase catalytic site, stabilizes Pol II at promoter-proximal pause sites prior to assembly into the super elongation complex (SEC), and participates in transcription restart after UV-induced DNA damage through Cdk7-dependent recruitment via TFIIH [PMID:8596958, PMID:11259417, PMID:22252557, PMID:24127601]. Beyond its elongation function, ELL acts as an E3 ubiquitin ligase that targets c-Myc for UbcH8-dependent proteasomal degradation through an active-site cysteine (C595), thereby inhibiting c-Myc-dependent proliferation, and additionally serves as a selective coactivator of the mineralocorticoid receptor and a direct DNA-binding transactivator of genes such as thrombospondin-1 [PMID:27009366, PMID:15650021, PMID:19447890]. ELL was identified as the gene fused to MLL in the t(11;19)(q23;p13.1) translocation that causes acute myeloid leukemia; leukemogenic transformation depends not on ELL's elongation domain but on its C-terminal domain that recruits the transcriptional coactivator EAF1 [PMID:7991593, PMID:11090074, PMID:11463848]. ELL and its associated factors EAF1/EAF2 localize to Cajal bodies and nuclear speckles in a transcription-dependent manner, and MLL-ELL disrupts these nuclear structures while also sequestering and inhibiting p53 [PMID:12686606, PMID:12446457, PMID:12773566].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"The identity of the gene at 19p13.1 disrupted in t(11;19) AML was unknown; cloning revealed ELL as a novel lysine-rich protein fused to MLL, establishing the first molecular link between this locus and leukemia.\",\n      \"evidence\": \"PCR cloning from patient leukemia cDNA library with Northern blot and evolutionary conservation analysis\",\n      \"pmids\": [\"7991593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional activity was assigned to ELL at this point\", \"The mechanism by which MLL-ELL drives leukemia was not addressed\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"The biochemical function of ELL was unknown; in vitro reconstitution demonstrated that ELL is an RNA Pol II elongation factor that increases the catalytic rate of transcription by suppressing transient pausing, establishing ELL's primary enzymatic activity.\",\n      \"evidence\": \"In vitro transcription elongation assay with purified components\",\n      \"pmids\": [\"8596958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of pause suppression at the nucleotide level was not resolved\", \"In vivo relevance of the elongation activity was not demonstrated\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"ELL nuclear localization was confirmed and a paralog ELL2 with 49% identity and equivalent elongation activity was identified, establishing that ELL defines a conserved family of elongation factors with the N-terminal region as the elongation activation domain.\",\n      \"evidence\": \"Immunofluorescence across multiple cell lines; molecular cloning and in vitro elongation assay for ELL2\",\n      \"pmids\": [\"9037066\", \"9108030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional redundancy versus specificity between ELL and ELL2 was unresolved\", \"ELL sub-nuclear compartmentalization was not yet characterized\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"It was unclear how ELL's activity on Pol II was regulated; identification of EAP30 as an ELL complex subunit that derepresses ELL's inhibitory effect on Pol II promoter-specific transcription revealed a built-in regulatory mechanism and a novel Pol II interaction domain in ELL.\",\n      \"evidence\": \"In vitro transcription reconstitution and protein interaction studies\",\n      \"pmids\": [\"10419521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full composition of the ELL complex was not determined\", \"Whether AML translocations exploit this regulatory domain was not tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Whether ELL's elongation activity was responsible for MLL-ELL leukemogenesis was unknown; structure-function analysis showed the C-terminal R4 domain (not the elongation domain) is necessary and sufficient for myeloid immortalization, establishing that MLL-ELL acts through transcriptional activation rather than elongation.\",\n      \"evidence\": \"Retroviral transduction of murine hematopoietic progenitors, serial replating assay, bone marrow transplantation, and transfection-based transcriptional assays with deletion mutants\",\n      \"pmids\": [\"10995463\", \"11090074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes of MLL-ELL-mediated transcriptional activation were not identified genome-wide\", \"How the R4 domain activates transcription molecularly was not defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The molecular basis of ELL's pause-suppression activity was unclear; biochemical reconstitution showed ELL prevents displacement of the nascent RNA 3′ end from the Pol II catalytic site and inhibits SII-induced transcript cleavage, defining the elongation mechanism. Simultaneously, the EAF1-interaction domain of ELL was shown to be critical for MLL-ELL transformation, with MLL-EAF1 alone sufficient for AML, revealing EAF1 recruitment as the leukemogenic mechanism.\",\n      \"evidence\": \"In vitro transcription/cleavage assays with purified factors; structure-function mutagenesis with retroviral transduction and mouse bone marrow transplantation\",\n      \"pmids\": [\"11259417\", \"11463848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF1's transactivation domain has specific cofactor partners was unknown\", \"Structural basis of ELL-Pol II interaction was not determined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Whether ELL interacts with additional EAF family members was unknown; EAF2 was identified as a second ELL-interacting partner that colocalizes in nuclear speckles, with MLL-ELL selectively retaining EAF1 but not EAF2 interaction, suggesting differential complex assembly in normal versus leukemic states.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, confocal microscopy, retroviral transformation assay\",\n      \"pmids\": [\"12446457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional distinction between EAF1 and EAF2 in normal ELL biology was not resolved\", \"Whether EAF2 loss contributes to leukemogenesis was not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The sub-nuclear compartment of ELL and consequences of MLL-ELL for nuclear organization were undefined; ELL and EAF1 were shown to reside in Cajal bodies in a Pol II transcription-dependent manner, and MLL-ELL leukemia cells exhibit disrupted Cajal bodies with delocalized coilin and EAF1. Separately, MLL-ELL was found to sequester and inhibit p53 via the ELL C-terminus, blocking p53 acetylation and p21 induction.\",\n      \"evidence\": \"Immunofluorescence colocalization with p80 coilin, pharmacological Pol II inhibition, confocal microscopy in leukemia cells; co-immunoprecipitation, p53 acetylation and apoptosis assays\",\n      \"pmids\": [\"12686606\", \"12773566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Cajal body disruption is causally linked to leukemogenesis or a secondary consequence was not established\", \"Whether wild-type ELL regulates p53 under physiological conditions was not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Whether ELL has roles beyond elongation was unclear; ELL was identified as a selective coactivator of the mineralocorticoid receptor that requires both its elongation and EAF1-interaction domains, extending ELL's function to steroid hormone signaling.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, transcriptional assays with domain mutants\",\n      \"pmids\": [\"15650021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological significance of ELL-MR interaction in aldosterone-responsive tissues was not demonstrated\", \"Whether ELL coactivation requires its Pol II elongation activity mechanistically was not dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Evolutionary conservation of ELL's elongation function was uncertain; the S. pombe ortholog SpELL was shown to form a two-subunit complex with SpEAF that stimulates Pol II elongation and pyrophosphorolysis, and its deletion causes 6-azauracil sensitivity, confirming deep conservation.\",\n      \"evidence\": \"Biochemical purification, in vitro elongation and pyrophosphorolysis assays, drug sensitivity assay in fission yeast\",\n      \"pmids\": [\"17150956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SpELL has functions beyond elongation analogous to mammalian ELL was not explored\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"In vivo evidence for ELL's role in transcriptional elongation at specific loci was lacking; Drosophila ELL was recruited to heat-shock loci upon induction, and its knockdown reduced phospho-Pol II levels at these loci, providing the first metazoan in vivo evidence that ELL is required for Pol II elongation at rapidly induced genes.\",\n      \"evidence\": \"RNAi in Drosophila, ChIP at heat shock loci, phospho-Pol II immunostaining\",\n      \"pmids\": [\"18562276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide scope of ELL-dependent elongation was not determined\", \"Functional distinction from ELL2 in vivo was not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Whether ELL acts as a direct DNA-binding transactivator was unknown; ELL was shown to bind the thrombospondin-1 promoter via its first 45 amino acids and transactivate TSP-1, with functional consequences for vasculogenesis in zebrafish, establishing a gene-specific transcriptional function distinct from general elongation.\",\n      \"evidence\": \"Deletion mutant transfection, promoter-reporter assays, ChIP, zebrafish in vivo analysis\",\n      \"pmids\": [\"19447890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How many other genes are directly transactivated by ELL's DNA-binding domain was not determined\", \"The DNA-binding mode and sequence specificity were not structurally resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"ELL's temporal relationship to the super elongation complex was undefined; depletion experiments and kinetic ChIP analysis revealed that ELL stabilizes Pol II recruitment and entry into the promoter-proximal pause site before SEC assembly, placing ELL upstream of SEC in the transcription cycle.\",\n      \"evidence\": \"ELL depletion, ChIP for Pol II and chromatin marks, kinetic analysis of transcription complex assembly at rapidly induced genes\",\n      \"pmids\": [\"22252557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ELL is transferred from pre-SEC to SEC complexes was not resolved\", \"Whether ELL's pre-SEC function is redundant with ELL2 was not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Whether ELL functions in DNA damage responses was unknown; ELL was identified as a TFIIH partner recruited to UV-damaged chromatin in a Cdk7-dependent manner, and its depletion severely impaired transcription restart after DNA repair, establishing a role for ELL in coupling DNA repair to transcription resumption.\",\n      \"evidence\": \"Unbiased proteomics, siRNA depletion, UV irradiation, Pol II ChIP and transcription restart assays\",\n      \"pmids\": [\"24127601\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ELL's elongation activity is specifically required for restart or whether its presence suffices was not dissected\", \"The mechanism of Cdk7-dependent ELL recruitment was not structurally resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"ELL was not known to possess ubiquitin ligase activity; reconstitution revealed ELL functions as an E3 ubiquitin ligase targeting c-Myc for proteasomal degradation via UbcH8, with C595 as the catalytic cysteine, demonstrating a wholly unexpected enzymatic function with tumor-suppressive consequences.\",\n      \"evidence\": \"In vitro ubiquitination reconstitution, C595A active-site mutagenesis, co-immunoprecipitation, proteasome inhibitor treatment, xenograft tumor model\",\n      \"pmids\": [\"27009366\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether c-Myc is the sole substrate of ELL's E3 ligase activity was not determined\", \"The structural basis for ELL's dual enzymatic activities (elongation and E3 ligase) was not resolved\", \"Independent replication of the E3 ligase activity has not been reported\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ELL coordinates its multiple activities — elongation factor, E3 ubiquitin ligase, DNA-binding transactivator, and nuclear receptor coactivator — within the same protein, and whether these represent context-dependent or simultaneously active functions, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of full-length ELL exists\", \"Genome-wide identification of direct ELL DNA-binding targets has not been performed\", \"Whether ELL's E3 ligase activity operates in the context of its elongation complexes is unknown\", \"Functional redundancy with ELL2 and ELL3 in mammalian systems has not been systematically addressed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 5, 7, 13, 17, 20]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 12, 14]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 11]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [8, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 7, 17, 20]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 7, 17, 20]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"complexes\": [\n      \"Super Elongation Complex (SEC)\",\n      \"ELL-EAF1 complex\",\n      \"ELL-EAF2 complex\",\n      \"ELL-EAP30 complex\"\n    ],\n    \"partners\": [\n      \"EAF1\",\n      \"EAF2\",\n      \"EAP30\",\n      \"TFIIH\",\n      \"MLL\",\n      \"AFF4\",\n      \"NR3C2\",\n      \"HIF1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}